Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MNRSK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HuB4-DGN462
|
|||||
| Synonyms |
HuB4-sulfo-SPDB-DGN462
Click to Show/Hide
|
|||||
| Organization |
Universit della Svizzera italiana; ImmunoGen, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
B-cell lymphoma [ICD11:2A86]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2.8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
DGN462
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Sulfo-SPDB
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.